Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02248649 · ClinicalTrials.gov registry record · NA
Telemedicine Intervention to Improve Cognitive Function
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT02248649: Completed NA study, sponsored by VA Office of Research and Development.
NCT02248649 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02248649, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
This project is investigating whether a home-based exercise program will reduce cognitive decline in patients with Parkinson's disease.
Primary Outcome
The ADAS-Cog includes items assessing memory, orientation, language, and praxis. Scores range from 0-70 (higher scores indicate worse cognitive function). Change = Score at 6-month - Score at Baseline.
Interventions
- BEHAVIORAL Health education
- BEHAVIORAL Structured physical activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2014-12-01 |
| Est. Completion | 2018-09-30 |
| Phase | NA |
What the finished NCT02248649 record still lists
NCT02248649 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Health education is the first listed.
NCT02248649 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02248649 about?
NCT02248649 is a clinical study titled "Telemedicine Intervention to Improve Cognitive Function". This project is investigating whether a home-based exercise program will reduce cognitive decline in patients with Parkinson's disease.
What is the current status of trial NCT02248649?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2014-12-01. Estimated completion is 2018-09-30.
What interventions are being tested in trial NCT02248649?
The interventions under investigation include: Health education (BEHAVIORAL), Structured physical activity (BEHAVIORAL).
Who is sponsoring clinical trial NCT02248649?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02248649's enrollment target sits among peer trials
160 628th of 2000 higher than 1,347 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI